Our Publications

As a science-driven company, we proudly publish numerous scientific papers every year in high-impact journals.

1 publication found

July 25, 2016

A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D

This randomized, double-blind, placebo-controlled phase III study was conducted to assess the efficacy and safety of oral calcitonin (SMC021) for the treatment of postmenopausal osteoporosis. A total of 4665 postmenopausal women with osteoporosis were randomized 1:1 to receive calcium and vitamin D plus either SMC021 tablets (0.8mg/d) or placebo for 36months. The primary endpoint was the proportion of patients with a new vertebral fracture.

Journals:

Bone

Authors:

Henriksen K , Byrjalsen I , Andersen JR , Bihlet AR , Russo LA , Alexandersen P , Valter I , Qvist P , Lau E , Riis BJ , Christiansen C , Karsdal MA , SMC021 investigators

Osteoporosis